The Opioid Epidemic and Its Impact On the Workplace

This webinar will address the opioid epidemic from the perspective of employers who wish to maintain safe workplaces and conduct drug and alcohol testing.  The program will teach employers how to distinguish between lawful and unlawful use of opioids by employees, and why that distinction is important for employment purposes.  As to lawful opioid use, employers will become familiar with the requirements of the Americans with Disabilities Act to make “reasonable accommodations” of disabled employees and to conduct the “direct threat” analysis when the use of medications may create a safety risk.  In addition, we will discuss how to address the suspicion of illegal drug use at work as well as employers’ legal obligations when an employee voluntarily discloses that he/she has a substance abuse problem and needs help.

Additionally, the presentation will address the impact of the opioid epidemic on employers’ drug and alcohol testing programs, including those regulated by federal Department of Transportation regulations and those regulated by state laws.  Finally, we will discuss what steps employers can take to address the opioid epidemic’s effects in the workplace.

Register below for this free webinar
DATE:
October 4, 2018
TIME: 2:00PM ET - 1:00PM CT - 11:00AM PT

Speaker:

Kathryn J. Russo
Kathryn J. Russo is a Principal in the Long Island office of Jackson Lewis P.C., where she has worked for 23 years.  She is a firm resource on the legal issues implicated in workplace drug and alcohol testing arising under federal, state and local laws, and is the Leader of the firm’s Drug Testing and Substance Abuse Management Practice Group.

Ms. Russo assists clients with workplace problems involving drugs and alcohol, and gives advice about compliance with all pertinent drug and alcohol testing laws. She prepares substance abuse policies to comply with all federal drug and alcohol testing regulations (including all agencies of the U.S. Department of Transportation), as well as the drug and alcohol testing laws of all 50 states. In addition, she defends employers in litigation where drug and alcohol test results are at issue, and frequently conducts “reasonable suspicion” training for employers in connection with their substance abuse policies. Ms. Russo also counsels employers on leave and disability management issues arising when employees seek leave for substance abuse rehabilitation.

Ms. Russo is the editor and a contributor to Jackson Lewis’s Drug and Alcohol Testing Law Advisor Blog, www.drugtestlawadvisor.com, a blog addressing developments in workplace drug and alcohol testing.

 Sponsor:

Orasure Technologies

OraSure Technologies offers testing products for drugs of abuse, cotinine and alcohol. The Intercept® Oral Fluid Drug Test is an FDA-cleared laboratory-based oral fluid drug testing system that enables accurate testing for drugs of abuse including marijuana, cocaine, PCP, amphetamines and opiates. With a fast and easy-to-administer collection process, the collected specimen is placed into a vial for transport to the laboratory for processing. Intercept® is ideal for workplace, criminal justice, and drug treatment centers, among others. www.orasure.com

Date: Oct 04, 2018

Time: 2:00 PM ET

Duration: 1 Hour

Your e-mail address is used to communicate with you about your registration, related products and services, and offers from select vendors. Refer to our Privacy Policy for additional information.